{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:57:35Z","timestamp":1791205055556,"version":"4.1.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,5,4]],"date-time":"2010-05-04T00:00:00Z","timestamp":1272931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,5,4]],"date-time":"2010-05-04T00:00:00Z","timestamp":1272931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/nrgastro.2010.58","type":"journal-article","created":{"date-parts":[[2010,5,4]],"date-time":"2010-05-04T11:01:46Z","timestamp":1272970906000},"page":"336-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development"],"prefix":"10.1038","volume":"7","author":[{"given":"Xavier","family":"Sagaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Van Cutsem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"De Hertogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Geboes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,4]]},"reference":[{"key":"BFnrgastro201058_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nri799","volume":"2","author":"F Martin","year":"2002","unstructured":"Martin, F. & Kearney, J. F. Marginal-zone B cells. Nat. Rev. Immunol. 2, 323\u2013335 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro201058_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1146\/annurev.immunol.23.021704.115728","volume":"23","author":"S Pillai","year":"2005","unstructured":"Pillai, S., Cariappa, A. & Moran, S. T. Marginal zone B cells. Annu. Rev. Immunol. 23, 161\u2013196 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrgastro201058_CR3","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/00003246-199904000-00050","volume":"27","author":"ML Brigden","year":"1999","unstructured":"Brigden, M. L. & Pattullo, A. L. Prevention and management of overwhelming postsplenectomy infection\u2014an update. Crit. Care Med. 27, 836\u2013842 (1999).","journal-title":"Crit. Care Med."},{"key":"BFnrgastro201058_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0046-8177(03)00422-2","volume":"35","author":"C Kruschinski","year":"2004","unstructured":"Kruschinski, C., Zidan, M., Debertin, A. S., Von Horsten, S. & Pabst, R. Age-dependent development of the splenic marginal zone in human infants is associated with different causes of death. Hum. Pathol. 35, 113\u2013121 (2004).","journal-title":"Hum. Pathol."},{"key":"BFnrgastro201058_CR5","volume-title":"World Health Organization Classification of Tumors: Pathology and Genetics: Tumors of Hemopoietic and Lymphoid Tissues","author":"E Jaffe","year":"2008","unstructured":"Jaffe, E., Harris, N., Stein, H. & Vardiman, J. World Health Organization Classification of Tumors: Pathology and Genetics: Tumors of Hemopoietic and Lymphoid Tissues (IARC, Lyon, 2008)."},{"key":"BFnrgastro201058_CR6","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1182\/blood.V96.10.3578","volume":"96","author":"V De Re","year":"2000","unstructured":"De Re, V.  et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 96, 3578\u20133584 (2000).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nrclinonc.2009.147","volume":"6","author":"AJM Ferreri","year":"2009","unstructured":"Ferreri, A. J. M., Dolcetti, R., Magnino, S., Doglioni, C. & Ponzoni, P. Chlamydial infection: the link with ocular adnexal lymphomas. Nat. Rev. Clin. Oncol. 6, 658\u2013669 (2009).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"BFnrgastro201058_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa031887","volume":"350","author":"M Lecuit","year":"2004","unstructured":"Lecuit, M.  et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 350, 239\u2013248 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201058_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0046-8177(00)80233-6","volume":"31","author":"E Roggero","year":"2000","unstructured":"Roggero, E.  et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum. Pathol. 31, 263\u2013268 (2000).","journal-title":"Hum. Pathol."},{"key":"BFnrgastro201058_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","volume":"114","author":"A Stefanovic","year":"2009","unstructured":"Stefanovic, A. & Lossos, I. S. Extranodal marginal zone lymphoma of the ocular adnexa. Blood 114, 501\u2013510 (2009).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1210\/jcem.87.1.8156","volume":"87","author":"C Thieblemont","year":"2002","unstructured":"Thieblemont, C.  et al. Primary thyroid lymphoma is a heterogeneous disease. J. Clin. Endocrinol. Met. 87, 105\u2013111 (2002).","journal-title":"J. Clin. Endocrinol. Met."},{"key":"BFnrgastro201058_CR12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","volume":"338","author":"AC Wotherspoon","year":"1991","unstructured":"Wotherspoon, A. C., Ortizhidalgo, C., Falzon, M. R. & Isaacson, P. G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338, 1175\u20131176 (1991).","journal-title":"Lancet"},{"key":"BFnrgastro201058_CR13","first-page":"147","volume":"85","author":"E Zucca","year":"2000","unstructured":"Zucca, E.  et al. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in southern Switzerland. Hematologica 85, 147\u2013153 (2000).","journal-title":"Hematologica"},{"key":"BFnrgastro201058_CR14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860\u2013867 (2002).","journal-title":"Nature"},{"key":"BFnrgastro201058_CR15","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1073\/pnas.95.5.2463","volume":"95","author":"T Goossens","year":"1998","unstructured":"Goossens, T., Klein, U. & Kuppers, R. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc. Natl Acad. Sci. USA 95, 2463\u20132468 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201058_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","volume":"25","author":"G Bonizzi","year":"2004","unstructured":"Bonizzi, G. & Karin, M. The two NF-\u03baB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280\u2013288 (2004).","journal-title":"Trends Immunol."},{"key":"BFnrgastro201058_CR17","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1126\/science.1090769","volume":"302","author":"AA Ruefli-Brasse","year":"2003","unstructured":"Ruefli-Brasse, A. A., French, D. M. & Dixit, V. M. Regulation of NF-\u03baB-dependent lymphocyte activation and development by paracaspase. Science 302, 1581\u20131584 (2003).","journal-title":"Science"},{"key":"BFnrgastro201058_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nri1629","volume":"5","author":"U Siebenlist","year":"2005","unstructured":"Siebenlist, U., Brown, K. & Claudio, E. Control of lymphocyte development by nuclear factor \u03baB. Nat. Rev. Immunol. 5, 435\u2013445 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro201058_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2008.07284.x","volume":"143","author":"G Packham","year":"2008","unstructured":"Packham, G. The role of NF-\u03baB in lymphoid malignancies. Br. J. Haematol. 143, 3\u201315 (2008).","journal-title":"Br. J. Haematol."},{"key":"BFnrgastro201058_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ajh.20874","volume":"82","author":"SY Oh","year":"2007","unstructured":"Oh, S. Y.  et al. Nongastric marginal zone B-cell lymphoma: analysis of 247 cases. Am. J. Hematol. 82, 446\u2013452 (2007).","journal-title":"Am. J. Hematol."},{"key":"BFnrgastro201058_CR21","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","volume":"101","author":"E Zucca","year":"2003","unstructured":"Zucca, E.  et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101, 2489\u20132495 (2003).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR22","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1053\/gast.2000.19579","volume":"119","author":"W Fischbach","year":"2000","unstructured":"Fischbach, W.  et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. Gastroenterology 119, 1191\u20131202 (2000).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201058_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/path.2096","volume":"211","author":"TFE Barth","year":"2007","unstructured":"Barth, T. F. E.  et al. Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma. J. Pathol. 211, 305\u2013313 (2007).","journal-title":"J. Pathol."},{"key":"BFnrgastro201058_CR24","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/0016-5085(91)90063-Q","volume":"101","author":"SB Cogliatti","year":"1991","unstructured":"Cogliatti, S. B.  et al. Primary B-cell gastric lymphoma\u2014a clinicopathological study of 145 patients. Gastroenterology 101, 1159\u20131170 (1991).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201058_CR25","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","volume":"95","author":"C Thieblemont","year":"2000","unstructured":"Thieblemont, C.  et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95, 802\u2013806 (2000).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR26","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/0016-5085(92)91723-H","volume":"102","author":"T Radaszkiewicz","year":"1992","unstructured":"Radaszkiewicz, T., Dragosics, B. & Bauer, P. Gastrointestinal malignant-lymphomas of the mucosa-associated lymphoid tissue\u2014factors relevant to prognosis. Gastroenterology 102, 1628\u20131638 (1992).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201058_CR27","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1200\/JCO.2001.19.18.3874","volume":"19","author":"P Koch","year":"2001","unstructured":"Koch, P.  et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma\u2014results of the prospective German multicenter study GIT NHL 01\/92. J. Clin. Oncol. 19, 3874\u20133883 (2001).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro201058_CR28","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1200\/JCO.2005.04.031","volume":"23","author":"P Koch","year":"2005","unstructured":"Koch, P.  et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German Multicenter Study (GIT NHL 02\/96). J. Clin. Oncol. 23, 7050\u20137059 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro201058_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1182\/blood-2009-06-228015","volume":"115","author":"V Craig","year":"2010","unstructured":"Craig, V.  et al. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood 115, 581\u2013591 (2010).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR30","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1056\/NEJM199405053301803","volume":"330","author":"J Parsonnet","year":"1994","unstructured":"Parsonnet, J.  et al. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330, 1267\u20131271 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201058_CR31","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0016-5085(97)70028-3","volume":"112","author":"M Eck","year":"1997","unstructured":"Eck, M.  et al. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 112, 1482\u20131486 (1997).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201058_CR32","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/0140-6736(92)90280-G","volume":"339","author":"C Doglioni","year":"1992","unstructured":"Doglioni, C., Wotherspoon, A. C., Moschini, A., Deboni, M. & Isaacson, P. G. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339, 834\u2013835 (1992).","journal-title":"Lancet"},{"key":"BFnrgastro201058_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/0140-6736(93)91408-E","volume":"342","author":"T Hussell","year":"1993","unstructured":"Hussell, T., Isaacson, P. G., Crabtree, J. E. & Spencer, J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342, 571\u2013574 (1993).","journal-title":"Lancet"},{"key":"BFnrgastro201058_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/gut.53.1.34","volume":"53","author":"W Fischbach","year":"2004","unstructured":"Fischbach, W., Goebeler-Kolve, M. E., Dragosics, B., Greiner, A. & Stolte, M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 53, 34\u201337 (2004).","journal-title":"Gut"},{"key":"BFnrgastro201058_CR35","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","volume":"23","author":"T Wundisch","year":"2005","unstructured":"Wundisch, T.  et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J. Clin. Oncol. 23, 8018\u20138024 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro201058_CR36","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1111\/j.1440-1746.2008.05553.x","volume":"23","author":"JL O'Rourke","year":"2008","unstructured":"O'Rourke, J. L. Gene expression profiling in Helicobacter-induced MALT lymphoma with reference to antigen drive and protective immunization. J. Gastroenterol. Hepatol. 23, S151\u2013S156 (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201058_CR37","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ajcp\/106.5.670","volume":"106","author":"D DeJong","year":"1996","unstructured":"DeJong, D.  et al. Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. Am. J. Clin. Pathol. 106, 670\u2013675 (1996).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrgastro201058_CR38","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.ejca.2009.03.010","volume":"45","author":"S Hellmig","year":"2009","unstructured":"Hellmig, S.  et al. Germline variations of the MALT1 gene as risk factors in the development of primary gastric B-cell lymphoma. Eur. J. Cancer 45, 1865\u20131870 (2009).","journal-title":"Eur. J. Cancer"},{"key":"BFnrgastro201058_CR39","first-page":"285","volume":"142","author":"T Hussell","year":"1993","unstructured":"Hussell, T., Isaacson, P. G., Crabtree, J. E., Dogan, A. & Spencer, J. Immunoglobulin specificity of low-grade B-cell gastrointestinal lymphoma of mucosa-associated lymphoid-tissue (MALT) type. Am. J. Pathol. 142, 285\u2013292 (1993).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro201058_CR40","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0016-5085(00)70167-3","volume":"118","author":"A Morgner","year":"2000","unstructured":"Morgner, A.  et al. Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology 118, 821\u2013828 (2000).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201058_CR41","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0002-9440(10)65012-2","volume":"156","author":"M Baens","year":"2000","unstructured":"Baens, M., Steyls, A., Geboes, K., Marynen, P. & Wolf-Peeters, C. The product of the t(11;18), an API2\u2013MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am. J. Pathol. 156, 1433\u20131439 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro201058_CR42","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","volume":"101","author":"B Streubel","year":"2003","unstructured":"Streubel, B.  et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 101, 2335\u20132339 (2003).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0092-8674(00)80957-5","volume":"96","author":"TG Willis","year":"1999","unstructured":"Willis, T. G.  et al. Bcl-10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96, 35\u201345 (1999).","journal-title":"Cell"},{"key":"BFnrgastro201058_CR44","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/sj.leu.2403813","volume":"19","author":"I Wlodarska","year":"2005","unstructured":"Wlodarska, I.  et al. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Leukemia 19, 1299\u20131305 (2005).","journal-title":"Leukemia"},{"key":"BFnrgastro201058_CR45","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1053\/hupa.2003.98","volume":"34","author":"HK Muller-Hermelink","year":"2003","unstructured":"Muller-Hermelink, H. K. Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas: marginal zone lymphomas. Hum. Pathol. 34, 336\u2013340 (2003).","journal-title":"Hum. Pathol."},{"key":"BFnrgastro201058_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1182\/blood.V99.1.3","volume":"99","author":"P Starostik","year":"2002","unstructured":"Starostik, P.  et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 99, 3\u20139 (2002).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1055\/s-0028-1109062","volume":"47","author":"W Fischbach","year":"2009","unstructured":"Fischbach, W.  et al. S3 guideline Helicobacter pylori and gastroduodenal ulcer disease. Z. Gastroenterol. 47, 68\u2013102 (2009).","journal-title":"Z. Gastroenterol."},{"key":"BFnrgastro201058_CR48","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1182\/blood-2002-11-3502","volume":"102","author":"HT Ye","year":"2003","unstructured":"Ye, H. T.  et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood 102, 1012\u20131018 (2003).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR49","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","volume":"18","author":"B Streubel","year":"2004","unstructured":"Streubel, B.  et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 18, 1722\u20131726 (2004).","journal-title":"Leukemia"},{"key":"BFnrgastro201058_CR50","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1182\/blood-2002-11-3502","volume":"102","author":"HT Ye","year":"2003","unstructured":"Ye, H. T.  et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood 102, 1012\u20131018 (2003).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR51","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","volume":"93","author":"J Dierlamm","year":"1999","unstructured":"Dierlamm, J.  et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93, 3601\u20133609 (1999).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR52","first-page":"2645","volume":"90","author":"N Roy","year":"1997","unstructured":"Roy, N.  et al. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. Blood 90, 2645 (1997).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR53","first-page":"961","volume":"6","author":"AG Uren","year":"2000","unstructured":"Uren, A. G.  et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6, 961\u2013967 (2000).","journal-title":"Mol. Cell"},{"key":"BFnrgastro201058_CR54","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0002-9440(10)64988-7","volume":"156","author":"ED Remstein","year":"2000","unstructured":"Remstein, E. D., James, C. D. & Kurtin, P. J. Incidence and subtype specificity of AP12\u2013MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am. J. Pathol. 156, 1183\u20131188 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro201058_CR55","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0002-9440(10)64948-6","volume":"156","author":"M Motegi","year":"2000","unstructured":"Motegi, M.  et al. API2\u2013MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am. J. Pathol. 156, 807\u2013812 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro201058_CR56","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1038\/sj.leu.2401918","volume":"14","author":"J Kalla","year":"2000","unstructured":"Kalla, J.  et al. Heterogeneity of the AP12\u2013MALT1 gene rearrangement in MALT-type lymphoma. Leukemia 14, 1967\u20131974 (2000).","journal-title":"Leukemia"},{"key":"BFnrgastro201058_CR57","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1182\/blood.V98.4.1182","volume":"98","author":"HX Liu","year":"2001","unstructured":"Liu, H. X.  et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear Bcl-10. Blood 98, 1182\u20131187 (2001).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR58","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/modpathol.2009.182","volume":"23","author":"X Sagaert","year":"2010","unstructured":"Sagaert, X.  et al. Comparative expressed sequence hybridization studies of t(11;18)(q21;q21)-positive and -negative gastric MALT lymphomas reveal both unique and overlapping gene programs. Mod. Pathol. 23, 458\u2013469 (2010).","journal-title":"Mod. Pathol."},{"key":"BFnrgastro201058_CR59","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1182\/blood.V95.12.4014","volume":"95","author":"B Alpen","year":"2000","unstructured":"Alpen, B.  et al. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 95, 4014\u20134015 (2000).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","volume":"357","author":"HX Liu","year":"2001","unstructured":"Liu, H. X.  et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357, 39\u201340 (2001).","journal-title":"Lancet"},{"key":"BFnrgastro201058_CR61","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1053\/gast.2001.25305","volume":"120","author":"T Sugiyama","year":"2001","unstructured":"Sugiyama, T.  et al. API2\u2013MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. Gastroenterology 120, 1884\u20131885 (2001).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201058_CR62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","volume":"8","author":"A Zullo","year":"2010","unstructured":"Zullo, A.  et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin. Gastroenterol. Hepatol. 8, 105\u2013110 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201058_CR63","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/j.1349-7006.2009.01128.x","volume":"100","author":"S Toracchio","year":"2009","unstructured":"Toracchio, S.  et al. Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas. Cancer Sci. 100, 881\u2013887 (2009).","journal-title":"Cancer Sci."},{"key":"BFnrgastro201058_CR64","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/modpathol.3800523","volume":"19","author":"X Sagaert","year":"2006","unstructured":"Sagaert, X., Laurent, M., Baens, M., Wlodarska, I. & De Wolf-Peeters, C. MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of Bcl-10 in the tumor cells. Mod. Pathol. 19, 225\u2013232 (2006).","journal-title":"Mod. Pathol."},{"key":"BFnrgastro201058_CR65","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/sj.leu.2403644","volume":"19","author":"B Streubel","year":"2005","unstructured":"Streubel, B., Vinatzer, U., Lamprecht, A., Raderer, M. & Chott, A. T(3;4)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 19, 652\u2013658 (2005).","journal-title":"Leukemia"},{"key":"BFnrgastro201058_CR66","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/sj.leu.2403185","volume":"18","author":"ED Remstein","year":"2004","unstructured":"Remstein, E. D., Kurtin, P. J., Einerson, R. R., Paternoster, S. F. & Dewald, G. W. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1. Leukemia 18, 156\u2013160 (2004).","journal-title":"Leukemia"},{"key":"BFnrgastro201058_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0165-4608(92)90130-Z","volume":"58","author":"AC Wotherspoon","year":"1992","unstructured":"Wotherspoon, A. C., Pan, L. X., Diss, T. C. & Isaacson, P. G. Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue. Cancer Genet. Cytogenet. 58, 35\u201338 (1992).","journal-title":"Cancer Genet. Cytogenet."},{"key":"BFnrgastro201058_CR68","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1048>3.0.CO;2-B","volume":"29","author":"R Achuthan","year":"2000","unstructured":"Achuthan, R.  et al. Novel translocation of the BCL10 gene in a case of mucosa associated lymphoid tissue lymphoma. Genes Chromosomes Cancer 29, 347\u2013349 (2000).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrgastro201058_CR69","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0002-9440(10)64630-5","volume":"157","author":"HT Ye","year":"2000","unstructured":"Ye, H. T.  et al. Bcl-10 expression in normal and neoplastic lymphoid tissue\u2014nuclear localization in MALT lymphoma. Am. J. Pathol. 157, 1147\u20131154 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro201058_CR70","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nri1352","volume":"4","author":"M Thome","year":"2004","unstructured":"Thome, M. CARMA1, Bcl-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4, 348\u2013359 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro201058_CR71","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1200\/JCO.2006.05.6150","volume":"24","author":"X Sagaert","year":"2006","unstructured":"Sagaert, X.  et al. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J. Clin. Oncol. 24, 2490\u20132497 (2006).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro201058_CR72","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/sj.leu.2404244","volume":"20","author":"E Haralambieva","year":"2006","unstructured":"Haralambieva, E.  et al. Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Leukemia 20, 1300\u20131303 (2006).","journal-title":"Leukemia"},{"key":"BFnrgastro201058_CR73","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1078-0432.1065.11.3","volume":"11","author":"AH Banham","year":"2005","unstructured":"Banham, A. H.  et al. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin. Cancer Res. 11, 1065\u20131072 (2005).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro201058_CR74","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1182\/blood-2004-03-1209","volume":"104","author":"SL Barrans","year":"2004","unstructured":"Barrans, S. L., Fenton, J. A. L., Banham, A., Owen, R. G. & Jack, A. S. Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood 104, 2933\u20132935 (2004).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR75","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans, C. P.  et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103, 275\u2013282 (2004).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR76","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000212058","volume":"26","author":"SL Han","year":"2009","unstructured":"Han, S. L.  et al. FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa-associated lymphoid tissue lymphomas. Dig. Surg. 26, 156\u2013162 (2009).","journal-title":"Dig. Surg."},{"key":"BFnrgastro201058_CR77","first-page":"8820","volume":"61","author":"AH Banham","year":"2001","unstructured":"Banham, A. H.  et al. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res. 61, 8820\u20138829 (2001).","journal-title":"Cancer Res."},{"key":"BFnrgastro201058_CR78","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/ni1358","volume":"7","author":"H Hu","year":"2006","unstructured":"Hu, H.  et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat. Immunol. 7, 819\u2013826 (2006).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro201058_CR79","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/gcc.1150","volume":"31","author":"TFE Barth","year":"2001","unstructured":"Barth, T. F. E.  et al. Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 31, 316\u2013325 (2001).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrgastro201058_CR80","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2141.2006.05969.x","volume":"133","author":"YP Zhou","year":"2006","unstructured":"Zhou, Y. P.  et al. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21). Br. J. Haematol. 133, 35\u201342 (2006).","journal-title":"Br. J. Haematol."},{"key":"BFnrgastro201058_CR81","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3324\/haematol.12221","volume":"93","author":"B Ferreira","year":"2008","unstructured":"Ferreira, B.  et al. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Hematologica 93, 670\u2013679 (2008).","journal-title":"Hematologica"},{"key":"BFnrgastro201058_CR82","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/gcc.20464","volume":"46","author":"N Fukuhara","year":"2007","unstructured":"Fukuhara, N.  et al. Chromosomal imbalances are associated with outcome of Helicobacter pylori eradication in t(11;18)(q21;q21)-negative gastric mucosa-associated lymphoid tissue lymphomas. Genes Chromosomes Cancer 46, 784\u2013790 (2007).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrgastro201058_CR83","first-page":"547","volume":"35","author":"T Kondo","year":"2009","unstructured":"Kondo, T.  et al. Accumulation of aberrant CpG hypermethylation by Helicobacter pylori infection promotes development and progression of gastric MALT lymphoma. Int. J. Oncol. 35, 547\u2013557 (2009).","journal-title":"Int. J. Oncol."},{"key":"BFnrgastro201058_CR84","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/modpathol.2008.194","volume":"22","author":"DH Sinn","year":"2009","unstructured":"Sinn, D. H., Kim, Y. H., Lee, E. J., Ko, Y. H. & Kim, K. M. Methylation and API2\/MALT1 fusion in colorectal extranodal marginal zone lymphoma. Mod. Pathol. 22, 314\u2013320 (2009).","journal-title":"Mod. Pathol."},{"key":"BFnrgastro201058_CR85","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/j.1469-0691.2009.02960.x","volume":"15","author":"C Belair","year":"2009","unstructured":"Belair, C., Darfeuille, F. & Staedel, C. Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship. Clin. Microbiol. Infect. 15, 806\u2013812 (2009).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFnrgastro201058_CR86","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/labinvest.2008.94","volume":"88","author":"ZY Zhang","year":"2008","unstructured":"Zhang, Z. Y.  et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab. Invest. 88, 1358\u20131366 (2008).","journal-title":"Lab. Invest."},{"key":"BFnrgastro201058_CR87","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/gcc.20264","volume":"45","author":"JM Jiang","year":"2006","unstructured":"Jiang, J. M., Lee, E. J. & Schmittgen, T. D. Increased expression of microRNA-155 in Epstein\u2013Barr virus transformed lymphoblastoid cell lines. Genes Chromosomes Cancer 45, 103\u2013106 (2006).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrgastro201058_CR88","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"QT Li","year":"2002","unstructured":"Li, Q. T. & Verma, I. M. NF-\u03baB regulation in the immune system. Nat. Rev. Immunol. 2, 725\u2013734 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro201058_CR89","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1097-2765(02)00697-4","volume":"10","author":"JL Pomerantz","year":"2002","unstructured":"Pomerantz, J. L. & Baltimore, D. Two pathways to NF-\u03baB. Mol. Cell. 10, 693\u2013695 (2002).","journal-title":"Mol. Cell."},{"key":"BFnrgastro201058_CR90","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.4049\/jimmunol.175.11.7162","volume":"175","author":"T Ohmae","year":"2005","unstructured":"Ohmae, T.  et al. Helicobacter pylori activates NF-\u03baB via the alternative pathway in B lymphocytes. J. Immunol. 175, 7162\u20137169 (2005).","journal-title":"J. Immunol."},{"key":"BFnrgastro201058_CR91","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0092-8674(01)00189-1","volume":"104","author":"J Ruland","year":"2001","unstructured":"Ruland, J.  et al. Bcl-10 is a positive regulator of antigen receptor-induced activation of NF-\u03baB and neural tube closure. Cell 104, 33\u201342 (2001).","journal-title":"Cell"},{"key":"BFnrgastro201058_CR92","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1074-7613(03)00293-0","volume":"19","author":"J Ruland","year":"2003","unstructured":"Ruland, J., Duncan, G. S., Wakeham, A. & Mak, T. W. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19, 749\u2013758 (2003).","journal-title":"Immunity"},{"key":"BFnrgastro201058_CR93","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/path.1715","volume":"205","author":"HT Ye","year":"2005","unstructured":"Ye, H. T.  et al. MALT lymphoma with t(14;18)(q32;q21)\/IGH\u2013MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J. Pathol. 205, 293\u2013301 (2005).","journal-title":"J. Pathol."},{"key":"BFnrgastro201058_CR94","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1182\/blood-2004-12-4785","volume":"106","author":"M Nakagawa","year":"2005","unstructured":"Nakagawa, M.  et al. MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10. Blood 106, 4210\u20134216 (2005).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR95","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0014-5793(01)02414-0","volume":"496","author":"O Gaide","year":"2001","unstructured":"Gaide, O.  et al. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-\u03baB activation. FEBS Lett. 496, 121\u2013127 (2001).","journal-title":"FEBS Lett."},{"key":"BFnrgastro201058_CR96","doi-asserted-by":"publisher","first-page":"11877","DOI":"10.1074\/jbc.M010512200","volume":"276","author":"J Bertin","year":"2001","unstructured":"Bertin, J.  et al. CARD11 and CARD14 are novel caspase recruitment domain (CARD)\/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-\u03baB. J. Biol. Chem. 276, 11877\u201311882 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201058_CR97","doi-asserted-by":"publisher","first-page":"30589","DOI":"10.1074\/jbc.M103824200","volume":"276","author":"LM Allister-Lucas","year":"2001","unstructured":"Allister-Lucas, L. M.  et al. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-\u03baB induction. J. Biol. Chem. 276, 30589\u201330597 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201058_CR98","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri1944","volume":"6","author":"DJ Rawlings","year":"2006","unstructured":"Rawlings, D. J., Sommer, K. & Moreno-Garcia, M. E. The CARMA1 signalosome links the signaling machinery of adaptive and innate immunity in lymphocytes. Nat. Rev. Immunol. 6, 799\u2013812 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro201058_CR99","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/ni830","volume":"3","author":"O Gaide","year":"2002","unstructured":"Gaide, O.  et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-\u03baB activation. Nat. Immunol. 3, 836\u2013843 (2002).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro201058_CR100","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1128\/MCB.24.1.164-171.2003","volume":"24","author":"D Wang","year":"2004","unstructured":"Wang, D.  et al. CD3\/CD28 co-stimulation-induced NF-\u03baB activation is mediated by recruitment of protein kinase C-\u03b8, Bcl10, and I\u03baB kinase \u03b2 to the immunological synapse through CARMA1. Mol. Cell. Biol. 24, 164\u2013171 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrgastro201058_CR101","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1097-2765(04)00236-9","volume":"14","author":"LJ Sun","year":"2004","unstructured":"Sun, L. J., Deng, L., Ea, C. K., Xia, Z. P. & Chen, Z. J. J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289\u2013301 (2004).","journal-title":"Mol. Cell"},{"key":"BFnrgastro201058_CR102","doi-asserted-by":"publisher","first-page":"19012","DOI":"10.1074\/jbc.M009984200","volume":"276","author":"P Lucas","year":"2001","unstructured":"Lucas, P.  et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-\u03baB signaling pathway. J. Biol. Chem. 276, 19012\u201319019 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201058_CR103","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2005.04.012","volume":"7","author":"HL Zhou","year":"2005","unstructured":"Zhou, H. L., Du, M. Q. & Dixit, V. M. Constitutive NF-\u03baB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 7, 425\u2013431 (2005).","journal-title":"Cancer Cell"},{"key":"BFnrgastro201058_CR104","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-05-4590","volume":"66","author":"M Baens","year":"2006","unstructured":"Baens, M.  et al. Selective expansion of marginal zone B cells in E\u00b5-API2\u2013MALT1 mice is linked to enhanced I\u03baB kinase \u03b3 polyubiquitination. Cancer Res. 66, 5270\u20135277 (2006).","journal-title":"Cancer Res."},{"key":"BFnrgastro201058_CR105","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1182\/blood-2004-06-2297","volume":"105","author":"L Ho","year":"2005","unstructured":"Ho, L.  et al. MALT1 and the API2\u2013MALT1 fusion act between CD40 and IKK and confer NF-\u03baB-dependent proliferative advantage and resistance against Fas-induced cell death in B cells. Blood 105, 2891\u20132899 (2005).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR106","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbrc.2005.06.058","volume":"334","author":"Y Hosokawa","year":"2005","unstructured":"Hosokawa, Y., Suzuki, H., Nakagawa, M., Lee, T. H. & Seto, M. AP12\u2013MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-\u03baB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-\u03baB activation. Biochem. Biophys. Res. Commun. 334, 51\u201360 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrgastro201058_CR107","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ni1561","volume":"9","author":"B Coornaert","year":"2008","unstructured":"Coornaert, B.  et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-\u03baB inhibitor A20. Nat. Immunol. 9, 263\u2013271 (2008).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro201058_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tibs.2004.11.001","volume":"30","author":"K Heyninck","year":"2005","unstructured":"Heyninck, K. & Beyaert, R. A20 inhibits NF-\u03baB activation by dual ubiquitin-editing functions. Trends Biochem. Sci. 30, 1\u20134 (2005).","journal-title":"Trends Biochem. Sci."},{"key":"BFnrgastro201058_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gcc.20499","volume":"47","author":"K Honma","year":"2008","unstructured":"Honma, K.  et al. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosomes Cancer 47, 1\u20137 (2008).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrgastro201058_CR110","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","volume":"114","author":"K Honma","year":"2009","unstructured":"Honma, K.  et al. TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 114, 2467\u20132475 (2009).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR111","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1182\/blood.V112.11.116.116","volume":"112","author":"U Novak","year":"2008","unstructured":"Novak, U.  et al. The NF-\u03baB negative regulator TNFAIP3 (A20) is commonly inactivated by somatic mutations and genomic deletions in marginal zone B-cell lymphomas. Blood 112, 116\u2013117 (2008).","journal-title":"Blood"},{"key":"BFnrgastro201058_CR112","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/ajg.2009.314","volume":"104","author":"A Zullo","year":"2009","unstructured":"Zullo, A.  et al. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis. Am. J. Gastroenterol. 104, 1932\u20131937 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201058_CR113","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/annonc\/mdn094","volume":"19","author":"E Zucca","year":"2008","unstructured":"Zucca, E. & Dreyling, M. Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 19, 70\u201371 (2008).","journal-title":"Ann. Oncol."},{"key":"BFnrgastro201058_CR114","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2141.2006.06444.x","volume":"136","author":"PF Ferrucci","year":"2007","unstructured":"Ferrucci, P. F. & Zucca, E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br. J. Haematol. 136, 521\u2013538 (2007).","journal-title":"Br. J. Haematol."},{"key":"BFnrgastro201058_CR115","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/annonc\/mdn760","volume":"20","author":"A Stathis","year":"2009","unstructured":"Stathis, A.  et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann. Oncol. 20, 1086\u20131093 (2009).","journal-title":"Ann. Oncol."},{"key":"BFnrgastro201058_CR116","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1136\/gut.2006.096420","volume":"56","author":"W Fischbach","year":"2007","unstructured":"Fischbach, W.  et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 56, 1685\u20131687 (2007).","journal-title":"Gut"},{"key":"BFnrgastro201058_CR117","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","volume":"52","author":"C Copie-Bergman","year":"2003","unstructured":"Copie-Bergman, C.  et al. Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 52, 1656 (2003).","journal-title":"Gut"}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2010.58.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2010.58","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2010.58.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T13:30:48Z","timestamp":1744291848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2010.58"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,4]]},"references-count":117,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFnrgastro201058"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2010.58","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,4]]},"assertion":[{"value":"4 May 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}